Schedule 13D ownership disclosure

TETRAPHASE PHARMA

Security class unavailable · CUSIP: 88165N204

Event date: 2020-06-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,085,000
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000920465-20-000104
Form type
SC 13D
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Jun 22, 2020
Reporting period
Jun 15, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub